G936-0425 Screening compound: N-[(2-chlorophenyl)methyl]-4-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonamido)methyl]cyclohexane-1-carboxamide

G936-0425 Screening compound: N-[(2-chlorophenyl)methyl]-4-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonamido)methyl]cyclohexane-1-carboxamide
G936-0425 Screening compound: N-[(2-chlorophenyl)methyl]-4-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonamido)methyl]cyclohexane-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G936-0425
N-[(2-chlorophenyl)methyl]-4-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonamido)methyl]cyclohexane-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G936-0425

Molecular Formula

C25H30ClN3O4S (C25 H30 ClN3 O4 S)

Compound Name

N-[(2-chlorophenyl)methyl]-4-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonamido)methyl]cyclohexane-1-carboxamide

IUPAC name

N-[(2-chlorophenyl)methyl]-4-[(2-oxo-2345-tetrahydro-1H-1-benzazepine-7-sulfonamido)methyl]cyclohexane-1-carboxamide

SMILES

O=C(C1CCC(CNS(c(cc2)cc(CCC3)c2NC3=O)(=O)=O)CC1)NCc(cccc1)c1Cl

InChI

InChI=1S/C25H30ClN3O4S/c26-22-6-2-1-4-20(22)16-27-25(31)18-10-8-17(9-11-18)15-28-34(32,33)21-12-13-23-19(14-21)5-3-7-24(30)29-23/h1-2,4,6,12-14,17-18,28H,3,5,7-11,15-16H2,(H,27,31)(H,29,30)

InChI Key

BXITZNHDVGDWCV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15076029

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

504.05

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.830

Distribution Coefficient, logD

3.830

Water Solubility, LogSw

-4.10

Polar Surface Area

91.754

Acid Dissociation Constant (pKa)

11.28

Base Dissociation Constant (pKb)

-2.52

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.00

G936-0425 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

CORONAVIRUS Library (20774 compounds)

PLpro Library (6343 compounds)

Protein-Protein Interaction Library (218420 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Recognition Elements PPI Library (24135 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with G936-0425 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G936-0425?
Check Price and Availability of G936-0425, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G936-0425 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G936-0425
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G936-0425
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G936-0425 available by request